Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: Evidence for association of a DRD2 allele

Neurology

Volumn 48, Issue 6, 1997, Pages 1589-1593

  Plante Bordeneuve V ^c   Taussig, D ^d   Thomas, F ^a   Said, G ^d   Wood, N W ^b   Marsden, C D ^b   Harding, A E ^b  

^a INSERM   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c BICÊTRE HOSPITAL   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER;

ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DNA DETERMINATION; DOPAMINERGIC TRANSMISSION; FAMILIAL DISEASE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 2542507783     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1589     Document Type: Article

References (27)

1. Golbe LI, Di Iorio G, Bonavita V, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996;40:767-775.
2. Denson MA, Wszolek ZK. Familial parkinsonism: our experience and review. Parkinsonism & Related Disorders 1995;1: 35-46.
3. Markopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 1995;38:373-378.
4. Degl'Innocenti F, Maurello MT, Marini P. A parkinsonian kindred. Ital J Neurol Sci 1989;10:307-310.
5. Maraganore DM, Harding AE, Marsden CD. A clinical and genetic study of familial Parkinson's disease. Mov Disord 1991;6:205-211.
6. Planté-Bordeneuve V, Taussig D, Thomas F, Ziégler M, Said G. A clinical and genetic study of familial cases of Parkinson's disease. J Neurol Sci 1995;33:164-172.
7. Lazzarini AM, Myers RH, Zimmerman TR, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506.
8. Amstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylase genes in Parkinson's disease. Lancet 1992;339:1017-1018.
9. Smith CAD, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377.
10. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-372.
11. Hotamisligil GS, Girmen AS, Fink JS, et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 1994;9:305-310.
12. Ho SL, Kapadi AL, Ramsden DB, Williams AC. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 1995;37:403-405.
13. Gasser T, Wszolek ZK, Trotfatter J, et al. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol 1994;36:387-396.
14. Planté-Bordeneuve V, Davis MB, Maraganore DM, Marsden DM, Harding AE. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:911-913.
15. Jeilinger K. New developments in the pathology of Parkinson's disease. Adv Neurol 1990;53:1-16.
16. Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1986;45:19-34.
17. Planté-Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease. Mov Disord 1994;9: 337-339.
18. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-980.
19. Strange PG. Dopamine receptors: structure and function. Prog Brain Res 1993;99:167-179.
20. Weyler W, Hsu YP, Breakfield XO. Biochemistry and genetics of monoamine oxidase. J Pharmacol Exp Ther 1990;47:391-417.
21. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
22. Vandenbergh DJ, Persico MA, Hawkins AL, et al. Human dopamine transporter gene (DAT 1) maps to chromosome 5p 15.3 and displays a VNTR. Genomics 1992;14:1104-1106.
23. Black GC, Chen ZY, Craig IW, Powell JF. Dinucleotide repeat polymorphism at the MAOA locus. Nucl Acid Res 1991;19:689.
24. Konradi C, Ozelius L, Breakfield XO. Highly polymorphic (GT)n repeat sequence intron II of the human MAOB gene. Genomics 1992;12:176-177.
25. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O, Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor. Genomics 1991; 10:527-530.
26. Tanaka Y, Murayama N, Tsukamoto K, Mizuno Y, Sano A, Kondo I. Genetic susceptibility to the Parkinson's disease. Am J Hum Genet 1993;53 (suppl 3):1236.
27. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995;57:487-498.